CAMPERDOWN, Australia & FLAGSTAFF, Ariz.--(BUSINESS WIRE)--W. L. Gore & Associates (Gore) today reported the first Australian patients enrolled in the Global Registry for Endovascular Aortic Treatment (GREAT). The Registry is part of Gore’s dedication to post-market surveillance, monitoring patient and device performance in an effort to improve clinical practice, and patient outcomes. Devices studied in the Registry include the GORE® TAG® Thoracic Endoprosthesis, GORE® EXCLUDER® AAA Endoprosthesis, and GORE® EXCLUDER® AAA Endoprosthesis featuring C3 Delivery System.
